Riskpilot← Back to searchSign inGet full accessZevra Denmark A/S
A/SActiveCVR 43259326Nordre Fasanvej 215Research and experimental development on natural sciences and engineering · NACE 7210Est. 20224 employees
Revenue 2024
DKK 71M
-666% vs 2023
EBITDA margin
-31.1%
+21% vs 2023
Equity ratio
-89.6%
Financial strength
Net profit 2024
DKK -132,1M
-544% vs 2023
| Revenue | DKK 71M | -666% |
| EBITDA | DKK -22,1M | +21% |
| Net profit | DKK -132,1M | -544% |
| Total assets | DKK 178,2M | -6% |
| Equity | DKK -159,6M | -480% |
| Employees | 4 | — |
Legal name
Zevra Denmark A/S
CVR number
43259326
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13. maj 2022
Share capital
DKK 400.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er forskning, udvikling, produktion, markedsføring, salg og/eller licensudstedelse af medicinske produkter til behandling af forskellige sygdomme samt hermed beslægtede aktiviteter efter bestyrelsens skøn.
Address
Nordre Fasanvej 215
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1.671 | -12.548 | 70.973 |
| Staff expenses | -10.338 | -15.284 | -20.349 |
| EBITDA | -12.009 | -27.832 | -22.077 |
| Depreciation & amort. | -0 | -356 | -6.976 |
| EBIT | -12.009 | -28.188 | -29.053 |
| Net financials | 29 | 1.586 | 333 |
| Profit before tax | -11.980 | -26.602 | -28.720 |
| Tax | -4.574 | -6.096 | 103.394 |
| Net profit | -7.406 | -20.506 | -132.114 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 199.206 | 189.146 | 178.169 |
| Equity | -7.006 | -27.513 | -159.627 |
| Long-term debt | 30.167 | 51.670 | 57.449 |
| Short-term debt | 175.118 | 164.659 | 274.954 |
| Total debt | 205.286 | 216.329 | 332.403 |
EBITDA margin
-31.1%
This company
15.8%
Market median
-297% vs market
20222024
Equity ratio
-89.6%
This company
38.2%
Market median
-335% vs market
20222024
Return on equity
-13211400000.0%
This company
18.4%
Market median
-71801087057% vs market
20222024
Net profit margin
-186.1%
This company
8.1%
Market median
-2398% vs market
20222024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20222024
Debt / equity
2.12×
This company
0.62×
Market median
-242% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-05-13 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
TS Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zevra Denmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Raymond La Duane Clifton | Chief Executive Officer | 0 companies |
| Timothy Sangiovanni | Chief Executive Officer | 0 companies |
| Rahsaan Waleed Thompson | Chairman | 0 companies |
| Travis Clark Mickle | Chairman | 0 companies |
| Thomas Weitemeyer | Board of Directors | 0 companies |
| Neil McFarlane | Chairman | 0 companies |